Agent Engineering Intern (Los Altos)

About the job

Los Altos, CA · Engineering · Internship · Semester/quarter or summer · Fully in-person

Company overview

In July 2026, Cheiron announced an $8 million seed round led by Menlo Ventures, bringing total funding to $13 million to date, with the backing and strategic support of industry veterans including Moderna co-founder and MIT Institute Professor Robert Langer, former Pfizer Chief Medical Officer Freda Lewis-Hall, Chai Discovery co-founder and CEO Josh Meier, former Starbucks CEO Laxman Narasimhan, and former Apple AI chief John Giannandrea.

Cheiron is building the first AI-native operating system designed to represent an entire drug program as a single connected system. The company's platform helps biopharma teams represent, reason over, and stress-test the full state of a drug development program, including the claims, evidence, assumptions, risks, decisions, and commitments that determine whether a therapy advances. In less than six months since launch, Cheiron has been adopted by tens of thousands of biopharma professionals and deployed by major drug developers, and is already used by 7 of Korea's top 10 biopharma companies.

Cheiron is expanding into pharmaceutical CMC (Chemistry, Manufacturing, and Controls) teams. CMC governs how a drug is made, tested, and kept consistent across its entire commercial life. The work involves hundreds of regulatory commitments, post-approval changes, and cross-market submissions. Today it runs on documents, spreadsheets, and institutional memory. Cheiron augments manual workflows with a CMC regulatory-specific intelligence and reasoning layer.